Altaris Capital Partners completed the acquisition of Meridian Medical Technologies, a global leader in emergency response and health security solutions, from Pfizer Inc.
Porton Pharma Solutions (Porton) received new purchase orders from Pfizer Ireland Pharmaceuticals, a subsidiary of Pfizer Inc., for contract development and manufacturing (CDMO) services. The total order value is $681 million, exceeding 50% of Porton's most recent audited annual revenue.
Pfizer announced the opening of a new, state-of-the-art clinical manufacturing facility in Durham, NC, as part of an $800 million investment over six years to build three gene therapy manufacturing facilities. The Durham facility will create more than 50 new jobs and is part of Pfizer's expansion of end-to-end gene therapy capabilities.
Flowserve said it supplied pumps, valves and seals to Pfizer to support COVID-19 vaccine production, including replacing a mechanical mixer seal on a vaccine line at Pfizer's Kalamazoo, Michigan plant. The announcement was made on 1 March 2021.
Harro Höfliger is building a high-performance vial packaging line at its Backnang site for delivery to Pfizer's Belgian production plant. The line will carton, label and serialise vaccine vials.
Croda International entered into a five-year agreement with Pfizer to supply novel excipients used in the manufacture of a COVID-19 vaccine candidate, with an initial three-year supply contract for four component excipients.
Croda entered into a five-year agreement with Pfizer to supply novel excipients for a COVID-19 vaccine candidate. The initial supply contract covers four component excipients for the first three years.
Pfizer is expanding its gene therapy operations in Sanford, North Carolina, with a $500 million investment and 300 jobs.
Corning and Pfizer announced a long-term, multiyear purchase and supply agreement for Corning Valor Glass vials for a portion of Pfizer's marketed drug products, pending regulatory approval. The release is dated 28 May 2020.
Pfizer is constructing a new 400,000-square-foot sterile drug manufacturing facility in Portage, Michigan. The project is expected to generate $465 million in total private investment and create 450 jobs.
GEA supplied fully automated tablet and capsule production equipment, including continuous blending technology, that has transformed Pfizer's Freiburg, Germany plant into a smart factory.
Pfizer is investing $147 million at its Portage, Michigan manufacturing complex, including a 98,500 sq ft warehousing and distribution expansion (completed) and a 10,000 sq ft aseptic processing center (under construction) for Act-O-Vial production.
Corning will develop Corning Valor Glass with Merck and Pfizer, and is expected to expand its facilities and build a new glass plant with an estimated investment of $500 million. The location was not stated.
Pfizer is continuing construction at its Rocky Mount, North Carolina site, increasing the scope of its sterile injectable manufacturing facility expansion from $159 million to $190 million, adding a 65,000-square-foot adjacent facility. No new jobs are expected.
ICU Medical Inc. completed its acquisition of Pfizer's Hospira Infusion Systems business, which includes IV pumps, solutions and devices. The deal adds a complete IV therapy portfolio and a broader global footprint.
| Site | Largest | Latest |
|---|---|---|
| Durham, United States | $68.5M | 2021-12-15 |
| Sanford, United States | $500.0M | 2020-11-02 |
| Portage, United States | $465.0M | 2018-07-01 |
| Rocky Mount, United States |
| $190.0M |
| 2017-02-21 |